ANCHOR LEAD: SHOULD EVERYONE RETURN TO INJECTABLE FLU VACCINES? ELIZABETH TRACEY REPORTS
Many people respond better to injected flu vaccines than to the inhaled version, a recent study concluded, but Aaron Milstone, an infectious disease expert at Johns Hopkins, says there is still a place for the inhaled vaccine.
MILSTONE: A lot of people don’t like to get flu vaccine because they think shots hurt. And FluMist, or the live attenuated nasal vaccine offers people an alternative to a shot which can be painful. So that’s been a very nice selling point to immunize a greater proportion of the population is to have an alternative. I think this is still a great vaccine, this is still a great alternative and it remains to be seen though whether in certain populations one may be better than another. :29
Milstone points out that those who responded well to the inhaled type of vaccine were those who had not received the injectable form in the past, but further studies are needed to determine which populations are most suitable for which vaccine. At Johns Hopkins, I’m Elizabeth Tracey